199 related articles for article (PubMed ID: 25596928)
1. MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor.
Yang F; Hu Y; Liu HX; Wan YJ
J Biol Chem; 2015 Mar; 290(10):6507-15. PubMed ID: 25596928
[TBL] [Abstract][Full Text] [Related]
2. Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway.
Yang F; Gong J; Wang G; Chen P; Yang L; Wang Z
Oncotarget; 2016 Nov; 7(46):75165-75175. PubMed ID: 27738335
[TBL] [Abstract][Full Text] [Related]
3. microRNA-192 suppresses the expression of the farnesoid X receptor.
Krattinger R; Boström A; Schiöth HB; Thasler WE; Mwinyi J; Kullak-Ublick GA
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1044-51. PubMed ID: 27079614
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells.
Selmin OI; Fang C; Lyon AM; Doetschman TC; Thompson PA; Martinez JD; Smith JW; Lance PM; Romagnolo DF
J Nutr; 2016 Feb; 146(2):236-42. PubMed ID: 26609171
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.
Peng Z; Chen J; Drachenberg CB; Raufman JP; Xie G
J Biol Chem; 2019 May; 294(21):8529-8542. PubMed ID: 30967475
[TBL] [Abstract][Full Text] [Related]
7. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.
Liang Y; Zhao Q; Fan L; Zhang Z; Tan B; Liu Y; Li Y
Biomed Pharmacother; 2015 Oct; 75():137-41. PubMed ID: 26320367
[TBL] [Abstract][Full Text] [Related]
9. Bile acids and colon cancer: Is FXR the solution of the conundrum?
Gadaleta RM; Garcia-Irigoyen O; Moschetta A
Mol Aspects Med; 2017 Aug; 56():66-74. PubMed ID: 28400119
[TBL] [Abstract][Full Text] [Related]
10. The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.
Shekhar R; Priyanka P; Kumar P; Ghosh T; Khan MM; Nagarajan P; Saxena S
J Biol Chem; 2019 Mar; 294(12):4381-4400. PubMed ID: 30679313
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.
Qu R; Hao S; Jin X; Shi G; Yu Q; Tong X; Guo D
Gene; 2018 Feb; 642():354-361. PubMed ID: 29128635
[TBL] [Abstract][Full Text] [Related]
12. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells.
Zhang Y; Gong W; Dai S; Huang G; Shen X; Gao M; Xu Z; Zeng Y; He F
Mol Cancer Res; 2012 Apr; 10(4):516-22. PubMed ID: 22446874
[TBL] [Abstract][Full Text] [Related]
14. The p53/miRNAs/Ccna2 pathway serves as a novel regulator of cellular senescence: Complement of the canonical p53/p21 pathway.
Xu S; Wu W; Huang H; Huang R; Xie L; Su A; Liu S; Zheng R; Yuan Y; Zheng HL; Sun X; Xiong XD; Liu X
Aging Cell; 2019 Jun; 18(3):e12918. PubMed ID: 30848072
[TBL] [Abstract][Full Text] [Related]
15. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer.
De Gottardi A; Touri F; Maurer CA; Perez A; Maurhofer O; Ventre G; Bentzen CL; Niesor EJ; Dufour JF
Dig Dis Sci; 2004 Jun; 49(6):982-9. PubMed ID: 15309887
[TBL] [Abstract][Full Text] [Related]
16. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.
Li J; Ying Y; Xie H; Jin K; Yan H; Wang S; Xu M; Xu X; Wang X; Yang K; Zheng X; Xie L
FASEB J; 2019 Jan; 33(1):1374-1388. PubMed ID: 30138038
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203.
Wang L; Wei Z; Wu K; Dai W; Zhang C; Peng J; He Y
Aging (Albany NY); 2018 Dec; 10(12):3662-3682. PubMed ID: 30530918
[TBL] [Abstract][Full Text] [Related]
18. Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand.
Yu J; Yang K; Zheng J; Zhao W; Sun X
Cancer Gene Ther; 2021 Jun; 28(6):590-601. PubMed ID: 33046820
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
Martínez-Fernández P; Hierro L; Jara P; Alvarez L
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
